首页 > 市场调查报告书 > 医疗设备

医学影像诊断手术用器具内视镜检查设备

市场调查报告书

商品编码

1634206

全球子宫镜市场 - 2025 - 2033

Global Hysteroscopes Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球子宫腔镜市场达到2.604亿美元，预计2033年将达到4.240亿美元，2025-2033年预测期间复合年增长率为5.6%。

子宫腔镜是一种用于对子宫内部进行目视检查的医疗仪器。它是一种专为妇科手术设计的内视镜。该装置由薄的管状结构组成，可以透过子宫颈（子宫下部）插入子宫。它通常配备光源和摄像头，使医生可以在监视器上即时查看子宫内膜。子宫腔镜检查通常在门诊或医院在局部或全身麻醉下进行，具体取决于手术的复杂程度。子宫腔镜经由子宫颈插入子宫，可使用二氧化碳或盐水溶液扩张子宫以提高可见度。

受妇科疾病盛行率上升和子宫腔镜微创手术不断进步等因素的推动，子宫镜市场正经历显着成长。例如，2024 年 5 月，女性健康医疗器材领域的主要领导者 Meditrina 宣布 FDA 510(k) 批准其第 2 代双极射频子宫腔镜系统。该新系统采用双极射频技术和名为 Aveta Glo 的新型双极射频设备，代表了微创妇科手术的重大进步。

市场动态：

驱动程式和限制

妇科疾病盛行率上升

妇科疾病盛行率的上升极大地推动了子宫腔镜市场的成长，预计将在预测期内推动市场成长。子宫肌瘤、子宫内膜息肉和异常子宫出血是常见的妇科疾病，通常需要子宫镜评估和治疗。由于年龄、生活方式的改变和意识的提高等因素，这些疾病的全球发病率正在上升。

例如，根据美国国立卫生研究院 (NIH) 的数据，子宫肌瘤是女性最常见但尚未充分研究的疾病之一。这些肿瘤通常称为肌瘤，主要影响育龄期的女性，高达 70% 的白人女性和超过 80% 的非裔女性在一生中被诊断出。此外，根据 DynaMed 报告，子宫内膜息肉在患有异常子宫出血的停经后患者中占 21%-28%，在患有异常子宫出血的停经前患者中占 10%-40%。

子宫内膜癌（子宫内膜癌）变得越来越常见，尤其是在停经后女性。例如，根据世界癌症研究基金会的数据，2022年子宫内膜癌新发病例为420,368例，其中中国为77,722例，美国为66,055例，俄罗斯为29,852例，日本为18,338例，印度为17,240例。子宫腔镜检查是检测子宫内膜癌的关键诊断工具，其在活检和子宫内膜异常生长评估中的应用至关重要，这增加了对先进子宫镜系统的需求。

併发症的风险

子宫腔镜手术相关併发症的风险是阻碍子宫镜市场成长的重要因素。虽然子宫腔镜检查通常被认为是微创且安全的，但它仍然存在一定的风险，可能会阻止患者和医疗保健提供者选择该手术。

子宫腔镜检查最严重的风险之一是子宫穿孔，即子宫腔镜刺穿子宫壁。儘管很少见，但这可能会导致出血、感染或附近器官受伤，需要立即介入。例如，根据美国国立卫生研究院发表的一项研究，子宫穿孔是子宫腔镜手术最常见的併发症之一，发生率为0.8-1.5%。子宫穿孔可能在子宫颈扩张或插入子宫腔镜期间发生。对此类併发症的恐惧可能会阻止患者选择子宫腔镜检查，从而限制其采用，特别是在医生经验不足的环境中。

另一个重要的担忧是手术过程中感染的可能性，特别是当外来器械被引入子宫时。感染可导致骨盆腔炎 (PID) 或子宫内膜炎等併发症，需要抗生素治疗。儘管感染的风险很低，但它仍然可能导致再次入院、额外的治疗和更长的恢復时间，这会影响患者的满意度和手术的整体吸引力。

过度出血是子宫腔镜手术期间可能出现的另一种併发症，特别是在子宫腔镜手术（例如子宫肌瘤切除术或息肉切除术）中。虽然通常使用电外科器械控制出血，但在某些情况下，可能需要进一步的手术介入。

有关此报告的更多详细资讯 - 索取样品

市场领导者和先驱
- 新兴先锋和杰出参与者
- 拥有最大销售品牌的知名领导者
- 拥有成熟产品的市场领导者
新兴新创企业和关键创新者
CXO 观点
最新进展和突破
案例研究/正在进行的研究
监管和报销情况
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东和非洲
波特五力分析
供应链分析
专利分析
SWOT分析
未满足的需求和差距
市场进入和扩张的推荐策略
情境分析：最佳情况、基本情况和最坏情况预测
定价分析和价格动态

第 5 章：子宫腔镜市场，依产品类型

硬质子宫腔镜
柔性子宫腔镜
抛弃式子宫腔镜

第 6 章：子宫镜市场（按应用）

子宫肌瘤切除术
息肉切除术
子宫内膜去除术
其他的

第 7 章：子宫镜市场（依最终用户）

医院
妇科诊所
门诊手术中心
其他的

第 8 章：子宫腔镜市场，按区域市场分析和成长机会

北美洲
- 我们
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
南美洲
- 巴西
- 阿根廷
- 南美洲其他地区
亚太
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲

第 9 章：竞争格局与市场定位

竞争概况和主要市场参与者
市占率分析与定位矩阵
策略伙伴关係、併购
产品组合和创新的主要发展
公司基准化分析

第 10 章：公司简介

Olympus Corporation

公司概况
产品组合和描述
财务概览
主要进展
SWOT分析

Stryker Corporation
Medtronic plc
Hologic, Inc.
KARL STORZ
Richard Wolf GmbH
Zhejiang Geyi Medical Instrument Co., Ltd
LiNA Medical ApS
Delmont imaging
Meditrina, Inc.

第 11 章：假设与研究方法

资料收集方法
数据三角测量
预测技术
数据验证和确认

第 12 章：附录

简介目录

Product Code: MD1458

The global hysteroscopes market reached US$ 260.4 million in 2024 and is expected to reach US$ 424.00 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

A hysteroscope is a medical instrument used for visual examination of the interior of the uterus (womb). It is a type of endoscope specifically designed for gynecological procedures. The device consists of a thin, tubular structure that can be inserted through the cervix (the lower part of the uterus) into the uterus. It is typically equipped with a light source and a camera, allowing the physician to view the uterine lining on a monitor in real time. Hysteroscopy is typically performed in an outpatient or hospital setting under local or general anesthesia, depending on the complexity of the procedure. The hysteroscope is inserted through the cervix into the uterus, and carbon dioxide or saline solution may be used to expand the uterus to improve visibility.

The hysteroscope market is experiencing significant growth, driven by factors such as the increasing prevalence of gynecological disorders and rising advancements in hysteroscopes for minimally invasive procedures. For instance, in May 2024, Meditrina, a key leader in women's health medical devices, announced the FDA 510(k) clearance of its Gen 2 bipolar RF hysteroscopy system. This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecology disorders

The rising prevalence of gynecology disorders is significantly driving the growth of the hysteroscopes market and is expected to drive the market over the forecast period. Uterine fibroids, endometrial polyps and abnormal uterine bleeding are common gynecological conditions that often necessitate hysteroscopic evaluation and treatment. The global incidence of these conditions is rising due to factors such as age, lifestyle changes, and increased awareness.

For instance, according to the National Institute of Health (NIH), Uterine leiomyomas are one of the most common and yet understudied diseases in women. These tumors, commonly known as fibroids, affect women mainly during their reproductive years and are diagnosed in up to 70% of white women and more than 80% of women of African ancestry during their lifetime. Additionally, according to DynaMed, endometrial polyps are reported in 21%-28% of postmenopausal patients with abnormal uterine bleeding and in 10%-40 % of premenopausal patients with abnormal uterine bleeding.

Endometrial cancer (cancer of the uterine lining) is becoming more common, especially in postmenopausal women. For instance, according to the World Cancer Research Fund, there were 420,368 new cases of endometrial cancer in 2022, including China with 77,722, the United States with 66,055, Russia with 29,852, Japan with 18,338 and India with 17,240. Hysteroscopy is a key diagnostic tool for detecting endometrial cancer, and its use in biopsies and assessments of the uterine lining for abnormal growths is essential, increasing the demand for advanced hysteroscopic systems.

Risk of complications

The risk of complications associated with hysteroscopic procedures is a significant factor hampering the growth of the hysteroscope market. While hysteroscopy is generally considered minimally invasive and safe, it still carries certain risks that can deter both patients and healthcare providers from opting for the procedure.

One of the most serious risks of hysteroscopy is uterine perforation, where the hysteroscope punctures the wall of the uterus. Although rare, this can lead to bleeding, infection, or injury to nearby organs, requiring immediate intervention. For instance, according to a study published by the National Institute of Health, uterine perforation is one of the most common complications of operative hysteroscopy with an incidence of 0.8-1.5%. Uterine perforation can happen during cervical dilation or during insertion of the hysteroscope. The fear of such complications can discourage patients from choosing hysteroscopy, limiting its adoption, especially in settings with less experienced practitioners.

Another significant concern is the potential for infection during the procedure, especially when foreign instruments are introduced into the uterus. Infections can lead to complications like pelvic inflammatory disease (PID) or endometritis, requiring antibiotic treatment. Though the risk of infection is low, it can still lead to hospital readmissions, additional treatments, and longer recovery times, which impacts patient satisfaction and the overall appeal of the procedure.

Excessive bleeding is another complication that can arise during hysteroscopic procedures, particularly in operative hysteroscopy (e.g., myomectomy or polypectomy). While bleeding is often controlled with the use of electrosurgical instruments, in some cases, it can lead to a need for further surgical intervention.

For more details on this report - Request for Sample

Segment Analysis

The global hysteroscopes market is segmented based on product type, application, end-user and region.

Product Type:

The disposable hysteroscope segment is expected to dominate the hysteroscopes market share

One of the primary advantages of disposable hysteroscopes is their single-use design, which eliminates the risk of cross-contamination and infection that can occur with reusable instruments. After each use, disposable hysteroscopes are discarded, ensuring that they are sterile for every procedure. The World Health Organization (WHO) has highlighted the importance of reducing infection risks in medical procedures, which has significantly influenced the adoption of single-use instruments like disposable hysteroscopes. Thus, many market players are focusing on disposable hysteroscopes.

For instance, in May 2024, Minerva Surgical announced the immediate and exclusive distribution of a new disposable hysteroscope that will be displayed at the Annual Clinical & Scientific Meeting of the American College of Obstetricians and Gynecologists in San Francisco, CA. The company plans to soon rebrand the new disposable hysteroscope as HERizon, and its goal is to redefine the standards of efficiency and accessibility in gynecological care.

While reusable hysteroscopes require significant upfront investment and maintenance costs (cleaning, sterilization, repairs), disposable hysteroscopes have a lower cost for healthcare facilities and eliminate the ongoing expenses associated with maintaining reusable equipment. This cost-effectiveness is particularly attractive to smaller healthcare providers and those in developing regions, where budget constraints are a concern.

Geographical Analysis

North America is expected to hold a significant position in the hysteroscopes market share

North America especially in the United States, is home to many leading and emerging manufacturers of hysteroscopes, such as Olympus Corporation, Karl Storz, UroViu Corp and Stryker Corporation, which continually push the envelope on technological innovations in the field. Innovations in high-definition cameras, flexible hysteroscopes, and single-use disposable models have contributed to the growth of the hysteroscope market in the region, as these advancements improve the accuracy, safety, and convenience of procedures.

For instance, in June 2022, UroViu Corp launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations. The single-use hysteroscope eliminates the need for reprocessing the equipment, and the ease-of-use, portability, and time-saving aspects of the Hystero-V mean more efficient and comfortable procedures for both doctors and patients.

In North America, there is a high level of awareness around women's health, with strong healthcare campaigns focusing on early diagnosis and treatment of gynecological conditions. Institutions like the U.S. Department of Health and Human Services have launched programs targeting early detection of gynecological cancers, which drives the use of hysteroscopy for diagnosis and treatment. Public awareness campaigns, such as National Women's Health Week in the U.S., encourage women to undergo routine gynecological screenings, including hysteroscopy for conditions like abnormal uterine bleeding and fibroids.

Asia-Pacific is growing at the fastest pace in the hysteroscopes market

The Asia-Pacific region is witnessing an increase in the availability of advanced hysteroscopy technology, including high-definition cameras, flexible scopes, and disposable hysteroscopes. These innovations are enhancing the appeal of hysteroscopy in diagnosing and treating gynecological conditions with greater accuracy and minimal risk of infection. Countries like Japan and South Korea are leaders in adopting cutting-edge medical technologies, which are contributing to the growth of the hysteroscope market in the region.

In November 2022, India Medtronic Private Limited launched the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA). Some of the commonly seen IUA include fibroids, polyps, retained products of conception, adhesions, malignancies or hyperplasia.

Competitive Landscape

The major global players in the hysteroscopes market include Olympus Corporation, Stryker Corporation, Medtronic plc, Hologic, Inc., KARL STORZ, Richard Wolf GmbH, Zhejiang Geyi Medical Instrument Co., Ltd, LiNA Medical ApS, Delmont imaging, Meditrina, Inc. and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hysteroscopes market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Market Introduction and Scope

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. Executive Insights and Key Takeaways

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region

3. Dynamics

3.1. Impacting Factors
- 3.1.1. Drivers
  - 3.1.1.1. Rising Prevalence of Gynecology Disorders
- 3.1.2. Restraints
  - 3.1.2.1. Risk of Complications
- 3.1.3. Opportunity
- 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest selling Brand
- 4.1.3. Market leaders with established Product
4.2. Emerging Startups and Key Innovators
4.3. CXO Perspectives
4.4. Latest Developments and Breakthroughs
4.5. Case Studies/Ongoing Research
4.6. Regulatory and Reimbursement Landscape
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. Asia Pacific
- 4.6.4. Latin America
- 4.6.5. Middle East & Africa
4.7. Porter's Five Force Analysis
4.8. Supply Chain Analysis
4.9. Patent Analysis
4.10. SWOT Analysis
4.11. Unmet Needs and Gaps
4.12. Recommended Strategies for Market Entry and Expansion
4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.14. Pricing Analysis and Price Dynamics

5. Hysteroscopes Market, By Product Type

5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 5.1.2. Market Attractiveness Index, By Product Type
5.2. Rigid Hysteroscope*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Flexible Hysteroscope
5.4. Disposable Hysteroscope

6. Hysteroscopes Market, By Application

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
6.2. Myomectomy*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Polypectomy
6.4. Endometrial Ablation
6.5. Others

7. Hysteroscopes Market, By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gynecology Clinics
7.4. Ambulatory Surgical Centers
7.5. Others

8. Hysteroscopes Market, By Regional Market Analysis and Growth Opportunities

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.6.1. U.S.
  - 8.2.6.2. Canada
  - 8.2.6.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.6.1. Germany
  - 8.3.6.2. U.K.
  - 8.3.6.3. France
  - 8.3.6.4. Spain
  - 8.3.6.5. Italy
  - 8.3.6.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.6.1. Brazil
  - 8.4.6.2. Argentina
  - 8.4.6.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.6.1. China
  - 8.5.6.2. India
  - 8.5.6.3. Japan
  - 8.5.6.4. South Korea
  - 8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking

10. Company Profiles

10.1. Olympus Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
- 10.1.5. SWOT Analysis
10.2. Stryker Corporation
10.3. Medtronic plc
10.4. Hologic, Inc.
10.5. KARL STORZ
10.6. Richard Wolf GmbH
10.7. Zhejiang Geyi Medical Instrument Co., Ltd
10.8. LiNA Medical ApS
10.9. Delmont imaging
10.10. Meditrina, Inc.